Aces Diagnostics
Aces Diagnostics is a biotechnology company that develops diagnostic solutions for Lyme Disease.
Series A ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredFeb 13, 2024 (2 years old)
Funding rounds
- Series A · amount undisclosedSource: sec.gov
- Website created
Team
TC
Tammy Crawford CEO
Investors
Companies like Aces Diagnostics
LLymeAlertSeed · Jul 2026
EElement Biosciences$175M Series B+ · Jun 2026
CClinChoice$150M Series B+ · Jul 2022
AAccufyDxSeed · Oct 2026
NNovirSeed · Aug 2026
CClear LabsSeries B+ · Jul 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/aces-diagnostics (get a free API key).